# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-110087
Filing Date
2025-11-13
Accepted
2025-11-13 16:57:16
Documents
5
Period of Report
2025-11-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea0265587-6k_scinai.htm | 6-K | 13006
2 | NOTICE AND PROXY STATEMENT OF ANNUAL GENERAL MEETING OF SHAREHOLDERS | ea026558701ex99-1_scinai.htm | EX-99.1 | 91380
3 | PROXY CARD | ea026558701ex99-2_scinai.htm | EX-99.2 | 1462
4 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 320612
5 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 317591
| Complete submission text file | 0001213900-25-110087.txt |  | 986251

Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 251479480
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)